These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
383 related articles for article (PubMed ID: 17608468)
1. Rationally designed dual inhibitors of HIV reverse transcriptase and integrase. Wang Z; Bennett EM; Wilson DJ; Salomon C; Vince R J Med Chem; 2007 Jul; 50(15):3416-9. PubMed ID: 17608468 [TBL] [Abstract][Full Text] [Related]
2. Pharmacophore and structure-activity relationships of integrase inhibition within a dual inhibitor scaffold of HIV reverse transcriptase and integrase. Wang Z; Tang J; Salomon CE; Dreis CD; Vince R Bioorg Med Chem; 2010 Jun; 18(12):4202-11. PubMed ID: 20576573 [TBL] [Abstract][Full Text] [Related]
3. A 3D QSAR study of a series of HEPT analogues: the influence of conformational mobility on HIV-1 reverse transcriptase inhibition. Kireev DB; Chrétien JR; Grierson DS; Monneret C J Med Chem; 1997 Dec; 40(26):4257-64. PubMed ID: 9435895 [TBL] [Abstract][Full Text] [Related]
4. Synthesis of pyrimidine and quinolone conjugates as a scaffold for dual inhibitors of HIV reverse transcriptase and integrase. Wang Z; Vince R Bioorg Med Chem Lett; 2008 Feb; 18(4):1293-6. PubMed ID: 18226894 [TBL] [Abstract][Full Text] [Related]
5. Design and synthesis of dual inhibitors of HIV reverse transcriptase and integrase: introducing a diketoacid functionality into delavirdine. Wang Z; Vince R Bioorg Med Chem; 2008 Apr; 16(7):3587-95. PubMed ID: 18314335 [TBL] [Abstract][Full Text] [Related]
6. QSAR for anti-HIV activity of HEPT derivatives. Bazoui H; Zahouily M; Boulajaaj S; Sebti S; Zakarya D SAR QSAR Environ Res; 2002 Oct; 13(6):567-77. PubMed ID: 12479372 [TBL] [Abstract][Full Text] [Related]
7. Conformational study of the HIV-1 reverse transcriptase inhibitor 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine (HEPT). Lawtrakul L; Hannongbua S; Beyer A; Wolschann P Biol Chem; 1999 Feb; 380(2):265-7. PubMed ID: 10195434 [TBL] [Abstract][Full Text] [Related]
8. N1-Heterocyclic pyrimidinediones as non-nucleoside inhibitors of HIV-1 reverse transcriptase. Mitchell ML; Son JC; Lee IY; Lee CK; Kim HS; Guo H; Wang J; Hayes J; Wang M; Paul A; Lansdon EB; Chen JM; Eisenberg G; Geleziunas R; Xu L; Kim CU Bioorg Med Chem Lett; 2010 Mar; 20(5):1585-8. PubMed ID: 20137928 [TBL] [Abstract][Full Text] [Related]
9. N1-Alkyl pyrimidinediones as non-nucleoside inhibitors of HIV-1 reverse transcriptase. Mitchell ML; Son JC; Guo H; Im YA; Cho EJ; Wang J; Hayes J; Wang M; Paul A; Lansdon EB; Chen JM; Graupe D; Rhodes G; He GX; Geleziunas R; Xu L; Kim CU Bioorg Med Chem Lett; 2010 Mar; 20(5):1589-92. PubMed ID: 20138513 [TBL] [Abstract][Full Text] [Related]
10. Design of non-nucleoside inhibitors of HIV-1 reverse transcriptase with improved drug resistance properties. 1. Hopkins AL; Ren J; Milton J; Hazen RJ; Chan JH; Stuart DI; Stammers DK J Med Chem; 2004 Nov; 47(24):5912-22. PubMed ID: 15537346 [TBL] [Abstract][Full Text] [Related]
11. Triazole derivatives as non-nucleoside inhibitors of HIV-1 reverse transcriptase--structure-activity relationships and crystallographic analysis. Kirschberg TA; Balakrishnan M; Huang W; Hluhanich R; Kutty N; Liclican AC; McColl DJ; Squires NH; Lansdon EB Bioorg Med Chem Lett; 2008 Feb; 18(3):1131-4. PubMed ID: 18083512 [TBL] [Abstract][Full Text] [Related]
12. Investigation of novel lipid-functionalized PNA monomers as potential HIV-1 non-nucleoside reverse transcriptase and/or integrase inhibitors. Thomas MG; Maga G; Mouscadet JF; Howarth NM Nucleosides Nucleotides Nucleic Acids; 2007; 26(8-9):1063-6. PubMed ID: 18058537 [TBL] [Abstract][Full Text] [Related]
13. Geometrically and conformationally restrained cinnamoyl compounds as inhibitors of HIV-1 integrase: synthesis, biological evaluation, and molecular modeling. Artico M; Di Santo R; Costi R; Novellino E; Greco G; Massa S; Tramontano E; Marongiu ME; De Montis A; La Colla P J Med Chem; 1998 Oct; 41(21):3948-60. PubMed ID: 9767632 [TBL] [